Evidence map›Paper›PMID 33435297›Full record

ArticleInternational journal of molecular sciences2021

Extracellular Vesicle-Mediated Purinergic Signaling Contributes to Host Microenvironment Plasticity and Metastasis in Triple Negative Breast Cancer.

Suzann Duan, Senny Nordmeier, Aidan E Byrnes, Iain L O Buxton

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Biogenesis and functional implications of extracellular vesicles in cancer metastasis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Suzann DuanDepartment of Pharmacology, School of Medicine, University of Nevada Reno, Reno, NV 89557, USA.ORCID 0000-0002-5129-0736
Senny NordmeierDepartment of Pharmacology, School of Medicine, University of Nevada Reno, Reno, NV 89557, USA.
Aidan E ByrnesDepartment of Pharmacology, School of Medicine, University of Nevada Reno, Reno, NV 89557, USA.
Iain L O BuxtonDepartment of Pharmacology, School of Medicine, University of Nevada Reno, Reno, NV 89557, USA.
University of Nevada, Reno · US

Funding

Regulation of CAP Protein S-Nitrosation in Preterm LaborR01HD091114 · NICHD · UNIVERSITY OF NEVADA RENO · PI BUXTON, IAIN L · 2018 to 2021
$2.0M
NICHD NIH HHS R01 HD091114NIH HHS HD091114NIH HHS P30CA042014-28S1
6 · The paper itself

Abstract

Metastasis accounts for over 90% of cancer-related deaths, yet the mechanisms guiding this process remain unclear. Secreted nucleoside diphosphate kinase A and B (NDPK) support breast cancer metastasis. Proteomic evidence confirms their presence in breast cancer-derived extracellular vesicles (EVs). We investigated the role of EV-associated NDPK in modulating the host microenvironment in favor of pre-metastatic niche formation. We measured NDPK expression and activity in EVs isolated from triple-negative breast cancer (MDA-MB-231) and non-tumorigenic mammary epithelial (HME1) cells using flow cytometry, western blot, and ATP assay. We evaluated the effects of EV-associated NDPK on endothelial cell migration, vascular remodeling, and metastasis. We further assessed MDA-MB-231 EV-induced proteomic changes in support of pre-metastatic lung niche formation. NDPK-B expression and phosphotransferase activity were enriched in MDA-MB-231 EVs that promote vascular endothelial cell migration and disrupt monolayer integrity. MDA-MB-231 EV-treated mice demonstrate pulmonary vascular leakage and enhanced experimental lung metastasis, whereas treatment with an NDPK inhibitor or a P2Y1 purinoreceptor antagonist blunts these effects. We identified perturbations to the purinergic signaling pathway in experimental lungs, lending evidence to support a role for EV-associated NDPK-B in lung pre-metastatic niche formation and metastatic outgrowth. These studies prompt further evaluation of NDPK-mediated EV signaling using targeted genetic silencing approaches.

Indexed as

Signal TransductionAnimalsCell LineCell Line, TumorCell MovementEndothelial CellsExtracellular VesiclesFemaleHumansLung NeoplasmsMiceMice, SCIDNM23 Nucleoside Diphosphate KinasesReceptors, Purinergic P2YTriple Negative Breast NeoplasmsTumor MicroenvironmentNM23 Nucleoside Diphosphate KinasesReceptors, Purinergic P2Yangiogenesisexosomesextracellular vesiclesmetastasisnucleoside diphosphate kinasepurinergic signalingtriple negative breast cancer

Identifiers

PMID33435297
PMCPMC7827112
OpenAlexW3118406011

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.